| Ytd | -45.01% | |
| 1y | -41.42% |
| Open | 5.26 | Prev Close | 5.26 | Low | 5.23 | High | 5.33 | Mkt Cap | 255.38M |
| Vol | 123.56K | Avg Vol | 707.29K | EPS | 1.20 | P/E | 4.38 | Forward P/E | 6.47 |
| Beta | 0.97 | Short Ratio | 1.83 | Inst. Own | 81.02% | Dividend | 0.24 | Div Yield | 4.58 |
| Ex Div Date | 11-29 | Earning | 08-06 | 50-d Avg | 5.50 | 200-d Avg | 8.36 | 1yr Est | 6.92 |
NUS News
PROVO, Utah--(BUSINESS WIRE)--Nu Skin Enterprises, Inc. (NYSE: NUS) today announced it will release
July's GVAS Dogs list highlights ten fair-priced, high-yield large-cap stocks, including IRSA Invers
Russell 2000 & 3000 Maybe Hold Forever Stocks (MHFS) featured high (>4%) dividends, attractive or ne
5 low price-to-sales stocks passed a value screen that combines valuation, debt and quality metrics
Nu Skin Enterprises (NUS) faces low profitability and macro-driven sales headwinds, with limited rec
EL, HELE, NUS, KVUE and IPAR stand out as beauty and cosmetics stocks backed by growth strategies fo
Nu Skin (NUS) witnessed a jump in share price last session on above-average trading volume. The late
EL, ELF, HELE and NUS are benefiting from growing skincare demand, product innovation and expanding
CAL, GIII, NUS, APLE and EVER screen as low price-to-sales value stocks with upside potential, backe
The June GVAS portfolio highlights 13 'safer,' fair-priced large-cap value stocks with strong divide
Price-to-sales screens can uncover discounted growth when earnings are thin, pairing low P/S with ba
Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers;
Low price-to-sales stocks like SCVL, NUS, APLE, COP and FAF screen as undervalued, with the setup hi
EL, NUS and COTY tap AI, wellness and innovation trends as beauty demand evolves across skincare, co
PROVO, Utah--(BUSINESS WIRE)--Nu Skin Enterprises, Inc. (NYSE: NUS), a global leader in beauty and w
Nu Skin Enterprises NYSE: NUS reported first-quarter 2026 results that management said were in line
Dallas, Texas--(Newsfile Corp. - May 8, 2026) - NU Skin Enterprises Inc. (NYSE: NUS): Stonegate Capi
Nu Skin Enterprises, Inc. (NUS) Q1 2026 Earnings Call Transcript
Nu Skin Enterprises (NUS) came out with quarterly earnings of $0.14 per share, missing the Zacks Con
Nu Skin Enterprises (NYSE:NUS) lowers FY2026 GAAP EPS guidance from $0.80-$1.20 to $0.70-$1.10 vs $1
Nu Skin Enterprises (NYSE:NUS) is looking for Q2 GAAP EPS of $0.15-$0.25 vs $0.23 analyst estimate.
Nu Skin Enterprises (NYSE:NUS) reported quarterly earnings of $0.14 per share which missed the analy
PROVO, Utah--(BUSINESS WIRE)---- $NUS--Nu Skin Enterprises Inc. (NYSE: NUS) today announced first qu
PROVO, Utah--(BUSINESS WIRE)---- $NUS--Nu Skin Enterprises, Inc. (NYSE: NUS) today announced its boa
Nu Skin Enterprises, Inc. (NYSE: NUS) today announced the appointment of Chelsea Lantz as interim Ch
Nu Skin Enterprises Inc. (NYSE:NUS) today announced the appointment of Chayce Clark as chief operati
Nu Skin Enterprises Inc (NYSE: NUS) reported Q4 2025 results that missed expectations, with EPS of 2
Nu Skin Enterprises (NYSE:NUS) sees FY2026 sales of $1.350 billion-$1.500 billion vs $1.530 billion
Nu Skin Enterprises (NYSE:NUS) sees Q1 sales of $320.000 million-$340.000 million vs $356.800 millio
Nu Skin Enterprises (NYSE:NUS) reported quarterly earnings of $0.29 per share which missed the analy
Investors should avoid speculative assets and risky stocks in volatile markets. Safe-haven options l
Nu Skin Enterprises (NYSE:NUS) raises FY2025 GAAP EPS guidance from $3.05-$3.25 to $3.15-$3.25 vs $3
Nu Skin Enterprises (NYSE:NUS) raises FY2025 Adj EPS guidance from $1.15-$1.35 to $1.25-$1.35 vs $1.
Nu Skin Enterprises (NYSE:NUS) is looking for Q4 GAAP EPS of $0.25-$0.35 vs $0.33 analyst estimate.
Nu Skin Enterprises (NYSE:NUS) reported quarterly earnings of $0.34 per share which beat the analyst
Nu Skin Enterprises (NYSE:NUS) reported quarterly earnings of $0.43 per share which beat the analyst
Nu Skin Enterprises (NYSE:NUS) is looking for Q3 GAAP EPS of $0.25-$0.35 vs $0.29 analyst estimate.
Nu Skin Enterprises (NYSE:NUS) raises FY2025 GAAP EPS guidance from $2.80-$3.20 to $3.05-$3.20 vs $0
Nu Skin Enterprises (NYSE:NUS) raises FY2025 Adj EPS guidance from $0.90-$1.30 to $1.15-$1.35 vs $0.
Nu Skin Enterprises (NYSE:NUS) is looking for Q2 GAAP EPS of $0.20-$0.30 vs $0.24 analyst estimate.
Nu Skin Enterprises (NYSE:NUS) affirms FY2025 Adj EPS guidance from $0.90-$1.30 to $0.90-$1.30 vs $0
Nu Skin Enterprises (NYSE:NUS) reported quarterly earnings of $0.23 per share which beat the analyst
On Monday, 369 companies set new 52-week lows.